Patent details

Basic Information

Publication number:

92991

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP047759469

Legal Status:

Active

Application number:

92991

First applicant's nationality:

Procedural language:

French

Paediatric Extension

SPC Extension Filing Date:

19/05/2020

SPC Extension Agent Name:

OFFICE FREYLINGER S.A.

SPC Extension Status:

Granted

SPC Extension Grant Date:

25/02/2021

SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:

EU/1/15/1046

Marketing Authorization Type:

Marketing Authorization Date:

23/11/2015

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

09/03/2016

First Marketing Authorization date:

23/11/2015

Grant date:

09/05/2016

Activation date:

06/05/2024

Publication date:

09/05/2016

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

06/05/2029

SPC Extension Expiration:

06/11/2029

Rejection date:

Withdrawal date:

Owner

From:

28/06/2017

 

 

Name:

Bioverativ Therapeutics Inc.

Address:

225 Second Avenue, Waltham MA 02451, United States (US)

History of Owners

From:

09/03/2016

To:

28/06/2017

Name:

BIOGEN HEMOPHILIA INC.

Address:

250 BINNEY STREET, CAMBRIDGE, MA 02142, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

09/03/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PETERS Robert, T.

Address:

United States (US)

2

Name:

MEZO Adam, R.

Address:

United States (US)

3

Name:

RIVERA Daniel, S.

Address:

United States (US)

4

Name:

BITONTI Alan, J.

Address:

United States (US)

5

Name:

STATTEL James, M.

Address:

United States (US)

6

Name:

LOW Susan, C.

Address:

United States (US)

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

SPCX1

Bulletin edition number:

2020/07

Publication date:

12/06/2020

Description:

Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:

SPCX2

Bulletin edition number:

2021/04

Publication date:

08/03/2021

Description:

Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

4

Bulletin Heading:

SPC3

Bulletin edition number:

2025/04

Publication date:

04/03/2025

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20170000215A

Date Registered:

28/06/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Bioverativ Therapeutics Inc.

Address:

225 Second Avenue, Waltham MA 02451, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

02/06/2025

Annual Fee Number:

22

Annual Fee Amount:

420 Euro

Expected Payer:

Last Annual Fee Payment Date:

26/04/2024

Last Annual Fee Paid Number:

21

Last Annual Fee Paid Amount:

410 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
19/05/2020	Application Form	4
19/05/2020	General Document	1
19/05/2020	Outgoing Correspondence	1
19/05/2020	FNET_DC_FRONTPAGE	1
25/02/2021	Publication	1
25/02/2021	Certificate	1
19/05/2020	Publication	1
19/05/2020	General Document	43
19/05/2020	General Document	3
28/06/2017	Request For Change	6
19/05/2020	General Document	42
25/02/2021	Outgoing Correspondence	1